 | Up a level |
Nuñez, Nicolas Gonzalo; Berner, Fiamma; Friebel, Ekaterina; Unger, Susanne; Wyss, Nina; Gomez, Julia Martinez; Purde, Mette-Triin; Niederer, Rebekka; Porsch, Maximilian; Lichtensteiger, Christa; Kramer, Rafaela; Erdmann, Michael; Schmitt, Christina; Heinzerling, Lucie; Abdou, Marie-Therese; Karbach, Julia; Schadendorf, Dirk; Zimmer, Lisa; Ugurel, Selma; Klümper, Niklas; ... (2023). Immune signatures predict development of autoimmune toxicity in patients with cancer treated with immune checkpoint inhibitors. Med (N Y), 4(2), 113-129.e7. Cell Press 10.1016/j.medj.2022.12.007
Berner, Fiamma; Bomze, David; Lichtensteiger, Christa; Walter, Vincent; Niederer, Rebekka; Hasan Ali, Omar; Wyss, Nina; Bauer, Jens; Freudenmann, Lena Katharina; Marcu, Ana; Wolfschmitt, Eva-Maria; Haen, Sebastian; Gross, Thorben; Abdou, Marie-Therese; Diem, Stefan; Knöpfli, Stella; Sinnberg, Tobias; Hofmeister, Kathrin; Cheng, Hung-Wei; Toma, Marieta; ... (2022). Autoreactive napsin A-specific T cells are enriched in lung tumors and inflammatory lung lesions during immune checkpoint blockade. Science immunology, 7(75), eabn9644. American Association for the Advancement of Science 10.1126/sciimmunol.abn9644
Purde, Mette‑Triin; Niederer, Rebekka; Wagner, ikolaus B.; Diem, Stefan; Berner, Fiamma; Hasan Ali, Omar; Hillmann, Dorothea; Bergamin, Irina; Joerger, Markus; Risch, Martin; Niederhauser, Christoph; Lenz, Tobias L.; Früh, Martin; Risch, Lorenz; Semela, David; Flatz, Lukas (2022). Presence of autoantibodies in serum does not impact the occurrence of immune checkpoint inhibitor-induced hepatitis in a prospective cohort of cancer patients. Journal of cancer research and clinical oncology, 148(3), pp. 647-656. Springer 10.1007/s00432-021-03870-6
Kolev, Mirjam; Diem, Stefan; Diem, Lara; G. Rodrigues, Susana; Berzigotti, Annalisa; Stirnimann, Guido; Semmo, Nasser (2022). Mycophenolate mofetil as second line treatment in autoimmune hepatitis – A retrospective single center analysis. Journal of translational autoimmunity, 5, p. 100172. Elsevier 10.1016/j.jtauto.2022.100172
Diem, Stefan; Gottstein, Bruno; Beldi, Guido; Semmo, Nasser; Diem, Lara F. (2021). Accelerated Course of Alveolar Echinococcosis After Treatment With Steroids in a Patient With Autoimmune Encephalitis. Cureus, 13(10), e18831. Cureus, Inc. 10.7759/cureus.18831
Herbrand, Amanda Katherina; Schmitt, Andreas M; Briel, Matthias; Ewald, Hannah; Goldkuhle, Marius; Diem, Stefan; Hoogkamer, Anouk; Joerger, Markus; Moffa, Giusi; Novak, Urban; Hemkens, Lars G; Kasenda, Benjamin (2021). Association of Supporting Trial Evidence and Reimbursement for Off-Label Use of Cancer Drugs. JAMA network open, 4(3), e210380. American Medical Association 10.1001/jamanetworkopen.2021.0380
Diem, Stefan; Fässler, Mirjam; Bomze, David; Ali, Omar Hasan; Berner, Fiamma; Niederer, Rebekka; Hillmann, Dorothea; Mangana, Joanna; Levesque, Mitchell P; Dummer, Reinhard; Risch, Lorenz; Recher, Mike; Risch, Martin; Flatz, Lukas (2019). Immunoglobulin G and Subclasses as Potential Biomarkers in Metastatic Melanoma Patients Starting Checkpoint Inhibitor Treatment. Journal of immunotherapy, 42(3), pp. 89-93. Wolters Kluwer Health 10.1097/CJI.0000000000000255
Fässler, Mirjam; Diem, Stefan; Mangana, Joanna; Hasan Ali, Omar; Berner, Fiamma; Bomze, David; Ring, Sandra; Niederer, Rebekka; Del Carmen Gil Cruz, Cristina; Pérez Shibayama, Christian Ivan; Krolik, Michal; Siano, Marco; Joerger, Markus; Recher, Mike; Risch, Lorenz; Güsewell, Sabine; Risch, Martin; Speiser, Daniel E; Ludewig, Burkhard; Levesque, Mitchell P; ... (2019). Antibodies as biomarker candidates for response and survival to checkpoint inhibitors in melanoma patients. Journal for immunotherapy of cancer, 7(1), p. 50. BioMed Central 10.1186/s40425-019-0523-2
Herbrand, Amanda Katherina; Schmitt, Andreas Michael; Briel, Matthias; Diem, Stefan; Ewald, Hannah; Hoogkamer, Anouk; Joerger, Markus; Mc Cord, Kimberly Alba; Novak, Urban; Sricharoenchai, Sirintip; Hemkens, Lars G; Kasenda, Benjamin (2019). Contrasting evidence to reimbursement reality for off-label use (OLU) of drug treatments in cancer care: rationale and design of the CEIT-OLU project. ESMO open, 4(6), e000596. BMJ 10.1136/esmoopen-2019-000596
Safroneeva, Ekaterina; Saner, Catherine; Rossel, Jean-Benoît; Golay, Delphine; Pittet, Valérie; Godat, Sébastien; Diem, Stefan; Aepli, Patrick; Sawatzki, Mikael; Borovicka, Jan; Burgmann, Konstantin; Juillerat, Pascal; Netzer, Peter; Sendensky, Alexander; Hruz, Petr; Girardin, Marc; Biedermann, Luc; Greuter, Thomas; Vavricka, Stephan; Michetti, Pierre; ... (2018). Cohort Profile: The Swiss Eosinophilic Esophagitis Cohort Study (SEECS). Inflammatory intestinal disease, 2(3), pp. 163-170. S. Karger AG 10.1159/000486131
Herbrand, Amanda; Schmitt, Andreas; Briel, Matthias; Diem, Stefan; Ewald, Hannah; Hoogkamer, Anouk; Joerger, Markus; Mc Cord, Kimberly; Novak, Urban; Sricharoenchai, Sirintip; Hemkens, Lars; Kasenda, Benjamin (29 July 2019). Contrasting Evidence to Reimbursement Reality for Off-label use 1 (OLU) of Drug Treatments in Cancer Care – Rationale and Design of 2 the CEIT-OLU-project (medRxiv). Cold Spring Harbor Laboratory 10.1101/19003152
